HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Xiao Selected Research

2,4-diaminohypoxanthine

1/2021GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Xiao Research Topics

Disease

111Neoplasms (Cancer)
10/2022 - 07/2003
32Rectal Neoplasms (Rectal Cancer)
01/2021 - 09/2007
23Breast Neoplasms (Breast Cancer)
10/2022 - 01/2007
18Neoplasm Metastasis (Metastasis)
02/2022 - 07/2003
17Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 08/2012
17Obstructive Sleep Apnea
11/2021 - 09/2003
15Infections
01/2022 - 01/2002
11Carcinogenesis
01/2022 - 08/2013
9Colonic Neoplasms (Colon Cancer)
08/2022 - 06/2015
9Triple Negative Breast Neoplasms
01/2022 - 05/2018
9Inflammation (Inflammations)
01/2022 - 10/2015
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2021 - 08/2012
8Hepatocellular Carcinoma (Hepatoma)
11/2021 - 07/2003
8Obesity
01/2020 - 01/2014
8Apnea
10/2018 - 01/2005
7Lymphoma (Lymphomas)
01/2022 - 02/2018
7Multiple Myeloma
10/2021 - 01/2018
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2020 - 01/2011
6Lung Neoplasms (Lung Cancer)
12/2021 - 12/2014
6Wounds and Injuries (Trauma)
12/2017 - 07/2010
5Hypoxia (Hypoxemia)
03/2022 - 09/2010
5Disease Progression
01/2022 - 07/2011
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2002
5Psoriasis (Pustulosis Palmaris et Plantaris)
08/2021 - 01/2020
5Leukemia
08/2021 - 08/2012
5Renal Cell Carcinoma (Grawitz Tumor)
12/2020 - 03/2013
5Insulin Resistance
01/2019 - 04/2004
4Pain (Aches)
09/2022 - 11/2011
4Fibrosis (Cirrhosis)
03/2022 - 02/2019
4Diarrhea
01/2022 - 02/2011
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2021
4Anastomotic Leak
12/2021 - 10/2012
4Residual Neoplasm
05/2021 - 01/2020
4Cardiovascular Diseases (Cardiovascular Disease)
02/2021 - 01/2019
4Carcinoma (Carcinomatosis)
01/2021 - 12/2009
4Hemorrhage
01/2020 - 07/2011
4Colitis
01/2019 - 12/2017
4Wound Infection (Wound Infections)
11/2018 - 10/2011
3Atopic Dermatitis (Atopic Eczema)
01/2022 - 10/2020
3Bites and Stings (Sting)
01/2022 - 04/2019
3Asthma (Bronchial Asthma)
01/2022 - 01/2007
3Fatigue
01/2021 - 01/2015
3Pneumonia (Pneumonitis)
01/2021 - 02/2012

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2002
15Chimeric Antigen ReceptorsIBA
01/2022 - 10/2018
15Messenger RNA (mRNA)IBA
01/2021 - 09/2002
14Pharmaceutical PreparationsIBA
01/2022 - 10/2012
13Biological ProductsIBA
08/2022 - 07/2011
12Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2010
10MicroRNAs (MicroRNA)IBA
12/2021 - 01/2017
8DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2004
8RNA (Ribonucleic Acid)IBA
01/2022 - 05/2017
7Indicators and Reagents (Reagents)IBA
01/2021 - 03/2010
6EnzymesIBA
01/2022 - 03/2011
6Small Interfering RNA (siRNA)IBA
08/2021 - 01/2009
6Oxygen (Dioxygen)IBA
01/2021 - 06/2007
5LipidsIBA
05/2022 - 04/2011
5Insulin (Novolin)FDA Link
01/2022 - 09/2003
5bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
10/2021 - 10/2018
5Glucose (Dextrose)FDA LinkGeneric
11/2019 - 04/2004
5LeptinIBA
01/2017 - 09/2003
4CytokinesIBA
01/2022 - 12/2017
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 04/2015
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 11/2011
4Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2012
4Circular RNAIBA
10/2021 - 03/2018
4VaccinesIBA
01/2021 - 01/2002
4Tyrosine Kinase InhibitorsIBA
11/2019 - 07/2011
4AcidsIBA
11/2019 - 07/2007
4CholesterolIBA
11/2019 - 09/2003
4Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2019 - 01/2016
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 01/2009
3ProdrugsIBA
02/2022 - 03/2011
3Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 01/2017
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2021
3CateninsIBA
01/2022 - 05/2016
3Trastuzumab (Herceptin)FDA Link
01/2022 - 09/2012
3Phospholipids (Phosphatides)FDA LinkGeneric
06/2021 - 07/2007
3B-Cell Maturation AntigenIBA
05/2021 - 10/2018
3MicellesIBA
03/2021 - 11/2019
3Interleukin-17 (Interleukin 17)IBA
03/2021 - 01/2020
3AdiponectinIBA
02/2021 - 01/2017

Therapy/Procedure

62Therapeutics
09/2022 - 09/2002
23Immunotherapy
10/2022 - 01/2003
21Neoadjuvant Therapy
01/2022 - 03/2008
17Drug Therapy (Chemotherapy)
10/2022 - 03/2008
8Colectomy
08/2022 - 06/2015
7Stem Cell Transplantation
01/2022 - 01/2020
6Radiotherapy
10/2020 - 03/2008
6Proctectomy
01/2020 - 07/2008
5Lymph Node Excision (Lymph Node Dissection)
08/2022 - 10/2013
5Hematopoietic Stem Cell Transplantation
10/2021 - 01/2004
4Operative Surgical Procedures
01/2021 - 06/2014
4Chemoradiotherapy
01/2018 - 03/2008
4Continuous Positive Airway Pressure
01/2018 - 04/2004
4Operative Time
08/2017 - 07/2011
3Transplantation
01/2022 - 01/2021
3Precision Medicine
01/2022 - 01/2021
3Laser Therapy (Surgery, Laser)
10/2021 - 04/2015
3Lasers (Laser)
10/2021 - 04/2015